2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care

Seidu, S.; Cos, X.; Brunton, S.; Harris, S. B.; Jansson, S. P. O.; Mata\\-Cases, M.; Neijens, A. M. J.; Topsever, P.; Khunti, K.

doi:10.1016/j.pcd.2022.02.002

2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care

Date

2022

Authors

dc.identifier.doi

10.1016/j.pcd.2022.02.002

dc.identifier.other

WOS:000813410400001

Publisher

ELSEVIER SCI LTD

DOI

10.1016/j.pcd.2022.02.002

Keywords

Type 2 diabetes , Cardiovascular disease , Cardiovascular risk factors , Multimorbidity , Therapeutic inertia , Therapeutic adherence , Heart failure , Chronic kidney disease , Elderly , Primary care , Patient\\-centred care , Shared decision making

URI

https://openaccess.acibadem.edu.tr/handle/11443/6969

Collections

WOS

Full item page

2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care

Date

Authors

Journal Title

Journal ISSN

Volume Title

dc.identifier.issn

dc.identifier.doi

dc.identifier.other

dc.description.volume

dc.description.issue

Publisher

DOI

Abstract

Description

Keywords

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By